⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MGRX News
Mangoceuticals, Inc. Common Stock
Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor Ready to Announce with Confidence?
newsfilecorp.com
MGRX
Form 8-K
sec.gov
MGRX
Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
globenewswire.com
MGRX
Form 8-K
sec.gov
MGRX
Form 8-K
sec.gov
MGRX
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
globenewswire.com
MGRX
Form 8-K
sec.gov
MGRX
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
globenewswire.com
MGRX
Form 8-K
sec.gov
MGRX
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
globenewswire.com
MGRX